Immune to Cancer: The CRI Blog
-
CICON24 Day 4 Recap: Pioneering Cellular Therapies and Cancer Vaccines Shape the Future of Cancer Treatment
Led by inaugural CRI Lloyd J. Old STAR, Yvonne Chen, PhD, from UCLA, day four of CICON24… -
CICON24 Day 3 Recap: Advances in T Cell Tolerance, Metabolism, and the Microbiome in Cancer Immunotherapy
Day three of CICON24 continued the momentum of the previous days with an impressive lineup of talks… -
CICON24 Day 2 Recap: Exploring Cancer Vaccines, Immune Health, and Future Therapies
NATIONAL HARBOR —Day two of CICON24 began with an impactful keynote by Cathy Wu, MD, from Dana… -
Introducing Dr. Alicia Zhou: A New Chapter in Leadership at the Cancer Research Institute
The Cancer Research Institute (CRI) is excited to announce a transformative moment in its history with the… -
CICON24 Day 1 Recap: Groundbreaking Research and Collaboration Driving the Future of Cancer Immunotherapy
NATIONAL HARBOR — CICON24 officially kicked off today at the Gaylord National Resort and Convention Center in… -
Prostate Cancer Awareness Month: Unlocking the Power of Immunotherapy to Combat a Common Men’s Cancer
Prostate cancer is the second most common for men, only trailing skin cancer. Approximately 1.3 million men… -
Blood Cancer Awareness Month: How Immunotherapy Fights Leukemia, Lymphoma, and Multiple Myeloma
‘Blood cancer’ is an all-encompassing term for cancers that impact millions of people globally every year. The… -
Key Discoveries from the AMADEUS Clinical Trial on Cancer Treatment
The Cancer Research Institute (CRI) is excited to share the findings from the AMADEUS clinical trial, which…

Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.